Weekly respiratory virus update, week 12, March 2025
Respiratory virus activity is currently high in the EU/EEA. Both flu and RSV epidemics are still ongoing. Individuals eligible for vaccination are strongly encouraged to get vaccinated. Preventive measures, such as frequent handwashing, maintaining physical distance, avoiding large gatherings, and wearing masks in healthcare settings can help reduce transmission and protect those at high risk […]
Does COVID-19 vaccination reduce the risk and duration of post COVID-19 condition?
This report addresses whether COVID-19 vaccination also reduces the risk and/or duration of a wide range of post-acute COVID-19 symptoms, commonly referred to as ‘long COVID’.
COVID-19 vaccination reduces risk of ‘long COVID’ in adults
COVID-19 vaccination reduced the risk of developing ‘long COVID’ by approximately 27% in adults fully vaccinated before infection, according to a literature review carried out by the European Centre for Disease Prevention and Control (ECDC).
Weekly respiratory virus update, week 11, March 2025
There is currently high respiratory virus activity in the EU/EEA. Both flu and RSV epidemics are still ongoing. Individuals eligible for vaccination are strongly encouraged to get vaccinated. Preventive measures, such as frequent handwashing, maintaining physical distance, avoiding large gatherings, and wearing masks in healthcare settings can help reduce transmission and protect those at high […]
Communicable disease threats report, 15 – 21 March 2025, week 12
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 15 – 21 March 2025 and includes updates on cholera, Middle East respiratory syndrome, an overview of respiratory virus epidemiology in the EU/EEA, avian influenza, chikungunya, Ebola, and the risk of severe infections, carriage and cross-border transfer of carbapenem-resistant bacteria in victims […]
External quality assessment of SARS-CoV-2 serology in European expert laboratories, April 2021
Erratum for Euro Surveill. 2021;27(42).
Variable Sensitivity of SARS-CoV-2 Molecular Detection in European Expert Laboratories: External Quality Assessment, June and July 2020
During the ongoing coronavirus disease 2019 (COVID-19) outbreak, robust detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a key element for clinical management and to interrupt transmission chains.
External quality assessment of molecular detection and variant typing of SARS-CoV-2 in European expert laboratories in 2023
The COVID-19 pandemic highlighted the importance of laboratory preparedness. Regular monitoring of diagnostic tools via external quality assessments (EQAs) is key to maintaining robust public health response service.
External quality assessments on COVID-19
ECDC is supporting a large number of targeted External Quality Assessment (EQA) schemes with voluntary participation by reference or primary laboratories, which are active members of EU surveillance networks.
Communicable disease threats report, 8 – 14 March 2025, week 11
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 8 – 15 March 2025 and includes updates on respiratory virus epidemiology in the EU/EEA, Legionnaires’ disease, chikungunya, mpox, Marburg virus, and Ebola.